University research records

University of Osijek

10 imported, source-linked research records. Published in the last five years.

Published in the last five years

10 matching research records

Topic: Canagliflozin and SGLT2. Only records linked to University of Osijek are included. Historical ingestion is still running; these are imported records, not a count of all research worldwide.

Back to university profile →

Showing 1–10 of 10 matching records. Counts update as records arrive.

  1. γδ T-cell interferon-γ production reflects metabolic improvement during SGLT2 inhibitor-based therapy in type 2 diabetes

    September 11, 2026 · 0 citations · Open access

    Open original record →
  2. Hemoglobin Trajectories on SGLT2 Inhibitor Therapy in Heart Failure: Anemia Marks Adverse Prognosis While Erythrocytosis Is Transient and Not Associated with Adverse Outcomes

    July 13, 2026 · 0 citations · Open access

    Open original record →
  3. Impact of Antidiabetic Medications on IgG and Plasma Protein N-Glycosylation in Type 2 Diabetes Patients

    June 22, 2026 · 0 citations · Open access

    Open original record →
  4. Heart Failure Etiology and 6-Month Cardiorenal Recovery Patterns After Early In-Hospital SGLT2 Inhibitor Initiation in HFrEF: A Prospective Real-World Cohort

    May 24, 2026 · 1 citations · Open access

    Open original record →
  5. GLP-1 Receptor Agonist Semaglutide and SGLT2 Inhibitors after Acute Coronary Syndrome in Patients with Diabetes: Real-World Comparative Outcomes from an Observational Registry

    April 14, 2026 · 0 citations

    Open original record →
  6. #2549 Real world data of dapagliflozin effect on proteinuria in primary glomerulopathies in Croatia

    May 1, 2024 · 1 citations · Open access

    Open original record →
  7. A Patient-Centered Management of Patients with Diabetes Type 2: Are All Diabetic Patients the Same?

    October 27, 2023 · 0 citations · Open access

    Open original record →
  8. Biomarkers for Assessing Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus on Sodium–Glucose Cotransporter 2 Inhibitor Therapy

    October 16, 2023 · 10 citations · Open access

    Open original record →
  9. Influence of Age, Gender, Frailty, and Body Mass Index on Serum IL-17A Levels in Mature Type 2 Diabetic Patients

    September 30, 2023 · 6 citations · Open access

    Open original record →
  10. Immunomodulatory Effects of SGLT2 Inhibitors—Targeting Inflammation and Oxidative Stress in Aging

    August 29, 2023 · 78 citations · Open access

    Open original record →